Edition:
India

DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

13.63USD
10:58pm IST
Change (% chg)

$0.30 (+2.25%)
Prev Close
$13.33
Open
$13.50
Day's High
$14.02
Day's Low
$13.40
Volume
20,093
Avg. Vol
55,533
52-wk High
$22.34
52-wk Low
$3.03

Latest Key Developments (Source: Significant Developments)

Dariohealth Says Selling Stockholders May Offer Up To 3.83 Million Shares Of Common Stock
Wednesday, 9 Sep 2020 

Sept 8 (Reuters) - DarioHealth Corp ::DARIOHEALTH CORP SAYS SELLING STOCKHOLDERS MAY OFFER UP TO 3.83 MILLION SHARES OF COMMON STOCK - SEC FILING.  Full Article

DarioHealth Launches New Blood Pressure Monitoring System
Tuesday, 30 Jul 2019 

July 30 (Reuters) - DarioHealth Corp ::DARIOHEALTH LAUNCHES NEW BLOOD PRESSURE MONITORING SYSTEM.DARIOHEALTH CORP - ADDITION OF A NEW DIGITAL MONITORING SOLUTION ON ITS DARIO APP PLATFORM THAT WILL ALLOW PATIENTS TO MONITOR THEIR BLOOD PRESSURE.  Full Article

Dariohealth Corp QTRLY Loss Per Share $0.15
Monday, 13 May 2019 

DarioHealth Corp ::DARIOHEALTH REPORTS RECORD RESULTS FOR FIRST QUARTER 2019.DARIOHEALTH CORP - Q1 REVENUES OF $2.2 MILLION, REPRESENTING 32% SEQUENTIAL REVENUE GROWTH OVER 4Q 2018.DARIOHEALTH CORP - Q1 BILLINGS OF $2.8 MILLION (NON-GAAP), REPRESENTING 37% SEQUENTIAL BILLINGS GROWTH OVER 4Q 2018.DARIOHEALTH CORP QTRLY LOSS PER SHARE $0.15.  Full Article

Dariohealth Granted License By Health Canada To Sell Dario Smart Glucose Meters For Lightning Connector Enabled iPhones
Wednesday, 20 Mar 2019 

March 20 (Reuters) - DarioHealth Corp ::PRESS RELEASE - DARIOHEALTH GRANTED LICENSE BY HEALTH CANADA TO SELL DARIO SMART GLUCOSE METERS FOR LIGHTNING® CONNECTOR ENABLED IPHONES.DARIOHEALTH CORP - EXPANSION OF DARIO'S CANADIAN MARKET OPPORTUNITY TO INCLUDE IPHONE 7, 8, AND IPHONE X USER.  Full Article

DarioHealth Corp Files For Offering Of Up To 6.1 Mln Shares Of Co's Common Stock By Selling Stockholders
Wednesday, 16 Jan 2019 

Jan 15 (Reuters) - DarioHealth Corp ::DARIOHEALTH CORP FILES FOR OFFERING OF UP TO 6.1 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING.  Full Article

Dariohealth Reports Third Quarter 2018 Results
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - DarioHealth Corp ::DARIOHEALTH REPORTS THIRD QUARTER 2018 RESULTS.Q3 REVENUE ROSE 37 PERCENT TO $1.88 MILLION.QUARTERLY LOSS PER SHARE $0.17.  Full Article

BRIEF-DarioHealth Presents Studies Showing Improvements In Blood Glucose & Blood Pressure Control

* DARIOHEALTH PRESENTS NEW STUDIES DEMONSTRATING SUSTAINED IMPROVEMENTS IN BLOOD GLUCOSE AND BLOOD PRESSURE CONTROL IN USERS WITH DIABETES AND HYPERTENSION AT THE AMERICAN DIABETES ASSOCIATION'S 80TH SCIENTIFIC SESSIONS Source text for Eikon: Further company coverage: